This resource was created by SMI Adviser content partners and approved by the SMI Adviser clinical expert team for inclusion in the knowledge base.
Transcranial magnetic stimulation (TMS) is a procedure for non-invasive stimulation of the brain. TMS was initially approved by the Food and Drug Administration (FDA) in 2008 as a treatment for major depression. It is now widely available at clinics and
hospitals across the country.
This fact sheet provides an overview of potential outcomes and side effects of TMS and how to discuss TMS with individuals and families.